Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2016 1
2017 2
2018 1
2020 1
2021 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Anti-CD20 monoclonal antibodies in multiple sclerosis.
Moreno Torres I, García-Merino A. Moreno Torres I, et al. Expert Rev Neurother. 2017 Apr;17(4):359-371. doi: 10.1080/14737175.2017.1245616. Epub 2016 Oct 21. Expert Rev Neurother. 2017. PMID: 27718747 Review.
Dimethyl fumarate-related immune and transcriptional signature is associated with clinical response in multiple sclerosis-treated patients.
Sánchez-Sanz A, García-Martín S, Sabín-Muñoz J, Moreno-Torres I, Elvira V, Al-Shahrour F, García-Grande A, Ramil E, Rodríguez-De la Fuente O, Brea-Álvarez B, García-Hernández R, García-Merino A, Sánchez-López AJ. Sánchez-Sanz A, et al. Among authors: moreno torres i. Front Immunol. 2023 Jul 7;14:1209923. doi: 10.3389/fimmu.2023.1209923. eCollection 2023. Front Immunol. 2023. PMID: 37483622 Free PMC article.
Risk and outcomes of COVID-19 in patients with multiple sclerosis.
Moreno-Torres I, Meca Lallana V, Costa-Frossard L, Oreja-Guevara C, Aguirre C, Alba Suárez EM, Gómez Moreno M, Borrega Canelo L, Sabín Muñoz J, Aladro Y, Cárcamo A, Rodríguez García E, Cuello JP, Monreal E, Sainz de la Maza S, Pérez Parra F, Valenzuela Rojas F, López de Silanes de Miguel C, Casanova I, Martínez Gines ML, Blasco R, Orviz García A, Villar-Guimerans LM, Fernández-Dono G, Elvira V, Santiuste C, Espiño M, García Domínguez JM. Moreno-Torres I, et al. Eur J Neurol. 2021 Nov;28(11):3712-3721. doi: 10.1111/ene.14990. Epub 2021 Jul 18. Eur J Neurol. 2021. PMID: 34152073 Free PMC article.
SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry.
Arrambide G, Llaneza-González MÁ, Costa-Frossard França L, Meca-Lallana V, Díaz EF, Moreno-Torres I, García-Domínguez JM, Ortega-Suero G, Ayuso-Peralta L, Gómez-Moreno M, Sotoca-Fernández JJ, Caminero-Rodríguez AB, Rodríguez de Antonio LA, Corujo-Suárez M, Otano-Martínez MA, Pérez-Miralles FC, Reyes-Garrido V, Ayuso-Blanco T, Balseiro-Gómez JJ, Muñoz-Pasadas M, Pérez-Molina I, Arnal-García C, Domingo-Santos Á, Guijarro-Castro C, Íñiguez-Martínez C, Téllez Lara N, Castellanos-Pinedo F, Castillo-Triviño T, Cerdán-Santacruz DM, Pérez-Sempere Á, Torres BS, Álvarez de Arcaya A, Costa-Arpín E, Durán-Ferreras E, Fragoso-Martínez M, González-Platas M, Landete Pascual L, Millán-Pascual J, Oreja-Guevara C, Meca-Lallana JE. Arrambide G, et al. Among authors: moreno torres i. Neurol Neuroimmunol Neuroinflamm. 2021 Jun 24;8(5):e1024. doi: 10.1212/NXI.0000000000001024. Print 2021 Jul. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 34168057 Free PMC article.
Three-Year Effectiveness of Dimethyl Fumarate in Multiple Sclerosis: A Prospective Multicenter Real-World Study.
Pilo de la Fuente B, Sabín J, Galán V, Thuissard I, Sainz de la Maza S, Costa-Frossard L, Gómez-Moreno M, Díaz-Díaz J, Oreja-Guevara C, Lozano-Ros A, García-Domínguez JM, Borrego L, Ayuso L, Castro A, Sánchez P, Meca-Lallana V, Muñoz C, Casanova I, López de Silanes C, Martín H, Rodríguez-García E, Andreu-Vázquez C, Blasco R, García-Merino JA, Aladro Y; Dimethyl Fumarate Study Group. Pilo de la Fuente B, et al. CNS Drugs. 2020 Dec;34(12):1275-1286. doi: 10.1007/s40263-020-00775-9. Epub 2020 Nov 23. CNS Drugs. 2020. PMID: 33226562
Immunophenotype and Transcriptome Profile of Patients With Multiple Sclerosis Treated With Fingolimod: Setting Up a Model for Prediction of Response in a 2-Year Translational Study.
Moreno-Torres I, González-García C, Marconi M, García-Grande A, Rodríguez-Esparragoza L, Elvira V, Ramil E, Campos-Ruíz L, García-Hernández R, Al-Shahrour F, Fustero-Torre C, Sánchez-Sanz A, García-Merino A, Sánchez López AJ. Moreno-Torres I, et al. Front Immunol. 2018 Jul 25;9:1693. doi: 10.3389/fimmu.2018.01693. eCollection 2018. Front Immunol. 2018. PMID: 30090102 Free PMC article.